Systemic therapies for metastatic renal cell carcinoma in older adults - Abstract - UroToday Print
UroToday
The introduction of targeted therapies has radically changed the treatment paradigm for metastatic renal cell carcinoma (mRCC). However, multiple clinical dilemmas have emerged. For instance, limited data are available to juxtapose the safety and

...